Northwestern chemists have cracked a nearly 30-year mystery by confirming the exact 3D structures of two rye pollen molecules — secalosides A and B — once shown to help animals fight tumors. By building the molecules from scratch in the lab, researchers now have a blueprint to explore how they interact with the immune system. This could open the door to nature-inspired cancer therapies.
Nearly three decades ago, scientists noticed something intriguing: two molecules in rye pollen appeared to slow tumor growth in animal studies. But the research stalled because no one could figure out the molecules' exact 3D structures — a critical detail for understanding how they work. Now, chemists at Northwestern University have finally cracked the code.
Using a painstaking lab technique called total synthesis — essentially building the molecules atom by atom from scratch — the team confirmed the precise structures of secalosides A and B for the first time. The challenge was formidable: both molecules contain an exceptionally rare, tightly compressed 10-membered ring at their core, which is notoriously difficult to assemble in a lab setting.
With the molecular blueprint now in hand, researchers can begin investigating how these compounds interact with the immune system and identify which parts may be driving their tumor-fighting effects — a key step toward developing new cancer therapies inspired by nature.
Key Takeaways:
Why it matters: Nature has long been a source of blockbuster drugs — from morphine to Taxol to statins. Solving this molecular puzzle gives scientists a concrete starting point to engineer better, more targeted versions of these compounds, potentially adding a new tool to the cancer treatment arsenal.
